BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecules and Cells

• Publication date

  2012-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molcel.2012.02.015PMID 22445484PMCID PMC3340543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fanconi anemia pathway : Repairing the link between DNA damage and quamous cell carcinoma

  2013cited by this paper
• Other options in the treatment of advanced breast cancer.

  2011cited by this paper
• Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1.

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair

  2011cited by this paper
• BRCA1 tumor suppression occurs via heterochromatin mediated silencing

  2011cited by this paper
• The MRE11 complex: starting from the ends

  2011cited by this paper
• Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells

  2011cited by this paper
• Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes

  2011influential reference
• 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.

  2010cited by this paper
• Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia.

  2010influential reference
• A new nuclease member of the FAN club

  2010cited by this paper
• DNA resection in eukaryotes: deciding how to fix the break

  2010cited by this paper
• Collaboration and competition between DNA double‐strand break repair pathways

  2010influential reference
• Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.

  2010cited by this paper
• Expanded roles of the Fanconi anemia pathway in preserving genomic stability.

  2010cited by this paper
• 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination

  2010cited by this paper
• 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

  2010cited by this paper
• Origin of chromosomal translocations in lymphoid cancer.

  2010cited by this paper
• Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway

  2010influential reference
• The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair

  2009cited by this paper
• CtIP-BRCA1 modulates the choice of DNA double-strand break repair pathway throughout the cell cycle

  2009cited by this paper
• A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency.

  2009cited by this paper
• 53BP1 facilitates long-range DNA end-joining during V(D)J recombination

  2008cited by this paper
• DNA helicases Sgs1 and BLM promote DNA double-strand break resection.

  2008cited by this paper
• 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility

  2008cited by this paper
• Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

  2007cited by this paper
• Human CtIP promotes DNA end resection

  2007cited by this paper
• Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

  2007influential reference
• ATM prevents the persistence and propagation of chromosome breaks in lymphocytes.

  2007cited by this paper
• Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair.

  2006cited by this paper
• BRCA1: A locus‐specific “liaison” in gene expression and genetic integrity

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005influential reference
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005influential reference
• Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.

  2005cited by this paper
• Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions.

  2004cited by this paper
• Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks

  2004cited by this paper
• 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination

  2004cited by this paper
• Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

  2003cited by this paper
• BRCA1-independent ubiquitination of FANCD2.

  2003influential reference
• p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice

  2003cited by this paper
• BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

  2002cited by this paper
• BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations

  2001cited by this paper
• Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

  2001influential reference
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cited by this paper
• Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

  2001cited by this paper
• The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*

  2000cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999influential reference
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999influential reference
• DNA end-joining: from yeast to man.

  1998cited by this paper
• Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.

  1997cited by this paper
• Cloning and characterization of rat Ku70: involvement of Ku autoantigen in the heat-shock response.

  1996cited by this paper
• Requirement for Ku80 in growth and immunoglobulin V(D)J recombination

  1996cited by this paper
• Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination.

  1994cited by this paper
• Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant.

  1994cited by this paper
• A DNA end-binding factor involved in double-strand break repair and V(D)J recombination

  1994cited by this paper
• Increased ratio of targeted to random integration after transfection of chicken B cell lines.

  1991cited by this paper

• Overview of Roles of Novel Components in the Regulation of DNA Damage Repair in BRCA1-Deficient Cancers: An Update

  2025cites this paper
• How to sensitize glioblastomas to temozolomide chemotherapy: a gap-centered view

  2024cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• E3 ligases: a ubiquitous link between DNA repair, DNA replication and human disease

  2024cites this paper
• Analysis for type of 53BP1 nuclear expression by immunofluorescence as an indicator of genomic instability in oropharyngeal squamous epithelial lesions

  2024cites this paper
• Feasibility and Clinical Utility of Routine HRD Testing in Newly Diagnosed High-Grade Advanced Ovarian Cancer

  2024cites this paper
• Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia

  2024cites this paper
• Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer

  2023cites this paper
• A Cell System-Assisted Strategy for Evaluating the Natural Antioxidant-Induced Double-Stranded DNA Break (DSB) Style

  2023cites this paper
• Brca1 mouse models: functional insights and therapeutic opportunities.

  2023cites this paper
• Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer

  2023cites this paper
• Comparative analysis of chlorambucil-induced DNA lesion formation and repair in a spectrum of different human cell systems

  2023cites this paper
• Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining.

  2023cites this paper
• Automatic identification of drug sensitivity of cancer cell with novel regression-based ensemble convolution neural network model

  2022cites this paper
• Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

  2022cites this paper
• Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours

  2022cites this paper
• The BRCA1 isoform, BRCA1-IRIS, operates independently of the full-length BRCA1 in the Fanconi anemia pathway

  2022cites this paper
• When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers.

  2022cites this paper
• RepID-deficient cancer cells are sensitized to a drug targeting p97/VCP segregase

  2021cites this paper
• Conserved and divergent features of DNA repair. Future perspectives in genome stability research

  2021cites this paper
• The ssDNA Theory of BRCAness and Genotoxic Agents

  2021cites this paper
• Animal models of Fanconi anemia: A developmental and therapeutic perspective on a multifaceted disease.

  2021cites this paper
• Fanconi anemia proteins participate in a break-induced-replication-like pathway to counter replication stress

  2021cites this paper
• Poly(ADP-ribose) polymerase inhibitors in prostate cancer: a cornerstone in precision oncology.

  2021cites this paper
• Dictyostelium discoideum as a Model to Assess Genome Stability Through DNA Repair

  2021cites this paper
• Prostate cancer and PARP inhibitors: progress and challenges

  2021cites this paper
• Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways

  2021influential citation
• Fanconi anemia and mTOR pathways functionally interact during stalled replication fork recovery

  2021cites this paper
• Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical Landscape

  2021cites this paper
• Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1

  2021cites this paper
• Changing the History of Prostate Cancer with New Targeted Therapies

  2021cites this paper
• BRCA1: a key player at multiple stages of homologous recombination in DNA double-strand break repair

  2021cites this paper
• BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients

  2021cites this paper
• Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis

  2021cites this paper
• To Join or Not to Join: Decision Points Along the Pathway to Double-Strand Break Repair vs. Chromosome End Protection

  2021cites this paper
• A Link between Replicative Stress, Lamin Proteins, and Inflammation

  2021cites this paper
• Mechanisms of Vertebrate DNA Interstrand Cross-Link Repair.

  2021cites this paper
• Bioinformatics and Molecular Analysis of the Breast Cancer Susceptibility Gene BRCA1 in Breast Cancer

  2020cites this paper
• Molecular Mechanisms of Arsenic-induced Disruption of DNA Repair.

  2020cites this paper
• Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis

  2020influential citation
• Drosophila Xrcc2 regulates DNA double-strand repair in somatic cells.

  2020cites this paper
• LESSONS LEARNED FROM UNDERSTANDING CHEMOTHERAPY RESISTANCE IN EPITHELIAL TUBO-OVARIAN CARCINOMA FROM BRCA1 AND BRCA2 MUTATION CARRIERS.

  2020cites this paper
• Evolving insights: how DNA repair pathways impact cancer evolution

  2020cites this paper
• SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells

  2020cites this paper
• Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition

  2020cites this paper
• Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment

  2020cites this paper
• Ablation of the Brca1–Palb2 Interaction Phenocopies Fanconi Anemia in Mice

  2020cites this paper
• FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.

  2020cites this paper
• SMARCAD1-mediated active replication fork stability maintains genome integrity

  2020cites this paper
• E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells

  2020cites this paper
• Therapeutic applications of PARP inhibitors in ovarian cancer.

  2020cites this paper
• Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer

  2020cites this paper
• Functional interaction between Fanconi anemia and mTOR pathways during stalled replication fork recovery

  2020influential citation
• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  2020cites this paper
• Replication Gaps Underlie BRCA Deficiency and Therapy Response

  2020cites this paper
• Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma.

  2020cites this paper
• Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16INK4a Expression

  2020cites this paper
• BRCA1 and homologous recombination: implications from mouse embryonic development

  2020cites this paper
• 53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice

  2020cites this paper
• Shieldin – the protector of DNA ends

  2019cites this paper
• PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms

  2019cites this paper
• The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B

  2019cites this paper
• A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

  2019cites this paper
• Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells

  2019cites this paper
• Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA

  2019cites this paper
• Holding All the Cards—How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability

  2019cites this paper
• The Fanconi Anemia Pathway in Cancer.

  2019cites this paper
• CtIP-BRCA1 complex and MRE11 maintain replication forks in the presence of chain terminating nucleoside analogs

  2019cites this paper
• The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse Spermatogenesis.

  2019cites this paper
• Nucleosome Remodeling by Fun30SMARCAD1 in the DNA Damage Response

  2019cites this paper
• USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair

  2019cites this paper
• Multi-omics analysis reveals the BRCA1 mutation and mismatch repair gene signatures associated with survival, protein expression, and copy number alterations in prostate cancer

  2019cites this paper
• Aberrations in DNA repair pathways in cancer and therapeutic significances.

  2019cites this paper
• PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.

  2019cites this paper
• Rucaparib in the landscape of PARP inhibition in ovarian cancer

  2019cites this paper
• The non-homologous end-joining activity is required for Fanconi anemia fetal HSC maintenance

  2019cites this paper
• FANCD2 Binding to H4K20me2 via a Methyl-Binding Domain Is Essential for Efficient DNA Cross-Link Repair

  2019cites this paper
• Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations

  2019cites this paper
• Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance

  2019cites this paper
• Moving Mountains—The BRCA1 Promotion of DNA Resection

  2019cites this paper
• Chapter 7 The BRCA 1 and BRCA 2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response , DNA Repair and Cancer Therapy

  2018cites this paper
• Fanconi anaemia and cancer: an intricate relationship

  2018cites this paper
• Repeat-mediated deletions can be induced by a chromosomal break far from a repeat, but multiple pathways suppress such rearrangements

  2018cites this paper
• PROCESSING OF 3′-BLOCKED DNA DOUBLE-STRAND BREAKS BY TYROSYL-DNA PHOSPHODIESTERASE 1, ARTEMIS AND POLYNUCLEOTIDE KINASE/ PHOSPHATASE

  2018cites this paper
• DNA repair and cell cycle checkpoint defects in a mouse model of ‘BRCAness’ are partially rescued by 53BP1 deletion

  2018cites this paper
• Studying the effects of DNA replication stress on genome integrity and cell viability

  2018cites this paper
• SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK‐mTOR signalling

  2018cites this paper
• Engineering protein folding and interactions: Towards potential novel therapeutic interventions

  2018cites this paper
• Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

  2018influential citation
• BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II–DNA complexes

  2018cites this paper
• Fork Protection and Therapy Resistance in Hereditary Breast Cancer

  2018cites this paper
• BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

  2018cites this paper
• The BARD1 BRCT Domain in Tumor Suppression and Genome Stability

  2018influential citation
• The DNA damage response at dysfunctional telomeres, and at interstitial and subtelomeric DNA double-strand breaks.

  2018influential citation
• Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks.

  2018cites this paper
• Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies

  2018cites this paper
• Regulation of DNA repair in the absence of classical non-homologous end joining.

  2018cites this paper
• Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells

  2018cites this paper
• The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells

  2018cites this paper
• Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier

  2018cites this paper